713 related articles for article (PubMed ID: 10514357)
21. Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.
Imamura Y; Shimizu K; Yamashita F; Yamaoka K; Takakura Y; Hashida M
Biol Pharm Bull; 2001 Aug; 24(8):930-4. PubMed ID: 11510488
[TBL] [Abstract][Full Text] [Related]
22. Examining P-gp efflux kinetics guided by the BDDCS - Rational selection of in vitro assay designs and mathematical models.
Riede J; Umehara KI; Schweigler P; Huth F; Schiller H; Camenisch G; Poller B
Eur J Pharm Sci; 2019 Apr; 132():132-141. PubMed ID: 30857914
[TBL] [Abstract][Full Text] [Related]
23. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats.
Hanafy A; Langguth P; Spahn-Langguth H
Eur J Pharm Sci; 2001 Feb; 12(4):405-15. PubMed ID: 11231107
[TBL] [Abstract][Full Text] [Related]
25. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
Hosoya KI; Kim KJ; Lee VH
Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
[TBL] [Abstract][Full Text] [Related]
26. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
27. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
Pharm Res; 1998 Jul; 15(7):1001-6. PubMed ID: 9688051
[TBL] [Abstract][Full Text] [Related]
28. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
29. Significance of Basal Membrane Permeability of Epithelial Cells in Predicting Intestinal Drug Absorption.
Yoshitomo A; Asano S; Hozuki S; Tamemoto Y; Shibata Y; Hashimoto N; Takahashi K; Sasaki Y; Ozawa N; Kageyama M; Iijima T; Kazuki Y; Sato H; Hisaka A
Drug Metab Dispos; 2023 Mar; 51(3):318-328. PubMed ID: 36810197
[TBL] [Abstract][Full Text] [Related]
30. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic kinetic modeling generates system-independent P-glycoprotein mediated transport elementary rate constants for inhibition and, in combination with 3D SIM microscopy, elucidates the importance of microvilli morphology on P-glycoprotein mediated efflux activity.
Ellens H; Meng Z; Le Marchand SJ; Bentz J
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):571-584. PubMed ID: 29788828
[TBL] [Abstract][Full Text] [Related]
32. The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation.
Senarathna SM; Page-Sharp M; Crowe A
PLoS One; 2016; 11(4):e0152677. PubMed ID: 27045516
[TBL] [Abstract][Full Text] [Related]
33. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.
Adachi Y; Suzuki H; Sugiyama Y
Pharm Res; 2001 Dec; 18(12):1660-8. PubMed ID: 11785684
[TBL] [Abstract][Full Text] [Related]
35. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.
Zhang Y; Benet LZ
Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492
[TBL] [Abstract][Full Text] [Related]
36. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
37. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.
Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C
J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377
[TBL] [Abstract][Full Text] [Related]
38. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.
Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J
PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943
[TBL] [Abstract][Full Text] [Related]
39. Absorptive and Secretory Transport of Selected Artemisinin Derivatives Across Caco-2 Cell Monolayers.
Heyns J; Willers C; Haynes RK; Wong HN; Hamman J; Gouws C
Curr Drug Deliv; 2018; 15(8):1183-1192. PubMed ID: 29779481
[TBL] [Abstract][Full Text] [Related]
40. Extrapolation of Elementary Rate Constants of P-glycoprotein-Mediated Transport from MDCKII-hMDR1-NKI to Caco-2 Cells.
Meng Z; Ellens H; Bentz J
Drug Metab Dispos; 2017 Feb; 45(2):190-197. PubMed ID: 27856526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
